Research progress of PET related radiomics in tumor prognosis

doi:10.3877/cma.j.issn.2095-2015.2023.02.009

Abstract

Abstract:

Radiomics provides a quantitative method to analyze the high-dimensional extractable data in medical images.Driven by the development of big data analysis and artificial intelligence, radiomics has developed rapidly and obtained remarkable progress in the field of tumor diagnosis and treatment in nuclear medicine recently.Radiomics still faces many challenges when it is considered for the clinical application.This review summarizes the research progress of radiomics in the prognosis evaluation of tumor using positron emission tomography(PET)imaging, as well as the challenges and future prospects, further it aims to provide some reference for the accurate medical analysis of PET imaging.

Key words: Positron emission tomography, Tumor, Radiomics, Machine learning, Prognosis, Research progress

Wenpeng Huang, Yongkang Qiu, Qi Yang, Lele Song, Zhao Chen, Yan Fan, Lei Kang. Research progress of PET related radiomics in tumor prognosis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(02): 104-110.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2023.02.009

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2023/V13/I02/104

References 63

1	Hyun SH，Kim HS，Choi SH，et al.Intratumoral heterogeneity of(18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma[J]．Eur J Nucl Med Mol Imaging，2016，43(8)：1461-1468.
2	Sollini M，Antunovic L，Chiti A，et al.Towards clinical application of image mining：a systematic review on artificial intelligence and radiomics[J]．Eur J Nucl Med Mol Imaging，2019，46(13)：2656-2672.
3	Mayerhoefer ME，Materka A，Langs G，et al.Introduction to Radiomics[J]．J Nucl Med，2020，61(4)：488-495.
4	Lambin P，Rios-Velazquez E，Leijenaar R，et al.Radiomics：extracting more information from medical images using advanced feature analysis[J]．Eur J Cancer，2012，48(4)：441-446.
5	Li P，Wang X，Xu C，et al.¹⁸F-FDG PET/CT radiomic predictors of pathologic complete response(pCR)to neoadjuvant chemotherapy in breast cancer patients[J]．Eur J Nucl Med Mol Imaging，2020，47(5)：1116-1126.
6	Jiang C，Zhao L，Xin B，et al.¹⁸F-FDG PET/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]．Quantitative Imaging in Medicine and Surgery，2022，12(8)：4135-4150.
7	Zwanenburg A，Vallières M，Abdalah M A，et al.The Image Biomarker Standardization Initiative：Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping[J]．Radiology，2020，295(2)：328-338.
8	Castiglioni I，Rundo L，Codari M，et al.AI applications to medical images：From machine learning to deep learning[J]．Phy Med，2021，83：9-24.
9	Obermeyer Z，Emanuel EJ.Predicting the Future-Big Data，Machine Learning，and Clinical Medicine[J]．New Engl J Med，2016，375(13)：1216-1219.
10	Cuaron J，Dunphy M，Rimner A．Role of FDG-PET scans in staging，response assessment，and follow-up care for non-small cell lung cancer[J]．Front Oncol，2012，2：208.
11	Li J，Liu Y，Dong W，et al.Identifying ¹⁸F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module[J]．Quantitative Imaging in Medicine and Surgery，2022，12(3)：1893-1908.
12	Krarup MMK，Nygård L，Vogelius IR，et al.Heterogeneity in tumours：Validating the use of radiomic features on ¹⁸F-FDG PET/CT scans of lung cancer patients as a prognostic tool[J]．Radiother Oncol，2020，144：72-78.
13	Kirienko M，Cozzi L，Antunovic L，et al.Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery[J]．Eur J Nucl Med Mol Imaging，2018，45(2)：207-217.
14	Yang L，Xu P，Li M，et al.PET/CT Radiomic Features：A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs[J]．Front Oncol，2022，12：894323.
15	Sepehri S，Tankyevych O，Upadhaya T，et al.Comparison and Fusion of Machine Learning Algorithms for Prospective Validation of PET/CT Radiomic Features Prognostic Value in Stage Ⅱ-Ⅲ Non-Small Cell Lung Cancer[J]．Diagnostics(Basel，Switzerland)，2021，11(4)：675.
16	Chen YH，Wang TF，Chu SC，et al.Incorporating radiomic feature of pretreatment ¹⁸F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma[J]．PloS One，2020，15(12)：e0244502.
17	Yang B，Ji HS，Zhou CS，et al.¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma[J]．Translational Lung Cancer Research，2020，9(3)：563-574.
18	Huang SY，Franc BL，Harnish RJ，et al.Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis[J]．NPJ Breast Cancer，2018，4：24.
19	Gómez OV，Herraiz JL，Udías JM，et al.Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on[18F]F-FDG PET/CT Radiomic Features for Metabolic Response Prediction of Metastatic Breast Cancer Lesions[J]．Cancers，2022，14(12)：2922.
20	Roy S，Whitehead TD，Li S，et al.Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer[J]．Eur J Nucl Med Mol Imaging，2022，49(2)：550-562.
21	Jiang C，Li A，Teng Y，et al.Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma[J]．Eur J Nucl Med Mol Imaging，2022，49(8)：2902-2916.
22	Aide N，Fruchart C，Nganoa C，et al.Baseline ¹⁸F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy[J]．European Radiology，2020，30(8)：4623-4632.
23	Lue KH，Wu YF，Lin HH，et al.Prognostic Value of Baseline Radiomic Features of 18 F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma[J]．Diagnostics(Basel)，2020，11(1)：36.
24	Zhou Y，Li J，Zhang X，et al.Prognostic Value of Radiomic Features of ¹⁸F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells[J]．Front Oncol，2022，12：834288.
25	Lue KH，Wu YF，Liu SH，et al.Prognostic Value of Pretreatment Radiomic Features of ¹⁸F-FDG PET in Patients With Hodgkin Lymphoma[J]．Clinical Nuclear Medicine，2019，44(10)：e559-e565.
26	Zhou Y，Zhu Y，Chen Z，et al.Radiomic Features of ¹⁸F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes[J]．Contrast Media & Molecular Imaging，2021，2021：6347404.
27	Wang H，Zhao S，Li L，et al.Development and validation of an ¹⁸F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma[J]．European Radiology，2020，30(10)：5578-5587.
28	Zhou Y，Ma XL，Pu LT，et al.Prediction of Overall Survival and Progression-Free Survival by the ¹⁸F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma[J]．Contrast Media & Molecular Imaging，2019，2019：5963607.
29	Gerstner ER，Zhang Z，Fink JR，et al.ACRIN 6684：Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using ¹⁸F-FMISO PET and MRI[J]．Clinical Cancer Research，2016，22(20)：5079-5086.
30	Muzi M，Wolsztynski E，Fink JR，et al.Assessment of the Prognostic Value of Radiomic Features in ¹⁸F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients：Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial[J]．Tomography，2020，6(1)：14-22.
31	Feliciani G，Fioroni F，Grassi E，et al.Radiomic Profiling of Head and Neck Cancer：¹⁸F-FDG PET Texture Analysis as Predictor of Patient Survival[J]．Contrast Media & Molecular Imaging，2018，2018：3574310.
32	Dmytriw AA，Ortega C，Anconina R，et al.Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT：Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up[J]．Cancers，2022，14(13)：3105.
33	Brodin N P，Velten C，Lubin J，et al.A positron emission tomography radiomic signature for distant metastases risk in oropharyngeal cancer patients treated with definitive chemoradiotherapy[J]．Physics and Imaging in Radiation Oncology，2022，21：72-77.
34	Nakajo M，Kawaji K，Nagano H，et al.The Usefulness of Machine Learning-Based Evaluation of Clinical and Pretreatment[18F]-FDG-PET/CT Radiomic Features for Predicting Prognosis in Hypopharyngeal Cancer[J]．Mol Imaging Biol，2022.
35	Rishi A，Zhang GG，Yuan Z，et al.Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer[J]．J Med Imaging Radiat Oncol，2021，65(1)：102-111.
36	Yh C，Kh L，Sc C，et al.Combining the radiomic features and traditional parameters of 18 F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery[J]．Ann Nucl Med，2019，33(9)：657-670.
37	Jiang Y，Yuan Q，Lv W，et al.Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits[J]．Theranostics，2018，8(21)：5915-5928.
38	Xue XQ，Yu WJ，Shi X，et al.¹⁸F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer[J]．Front Oncol，2022，12：911168.
39	Blanc-Durand P，Van Der Gucht A，Jreige M，et al.Signature of survival：a ¹⁸F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma[J]．Oncotarget，2018，9(4)：4549-4558.
40	Lee JW，Na JO，Kang DY，et al.Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection[J]．Clinical Lung Cancer，2017，18(2)：198-206.
41	Lee JW，Ban MJ，Park JH，et al.Effect of F-18 Fluorodeoxyglucose Uptake by Bone Marrow on the Prognosis of Head and Neck Squamous Cell Carcinoma[J]．J Clin Med，2019，8(8)：E1169.
42	Lee JW，Park SH，Ahn H，et al.Predicting Survival in Patients with Pancreatic Cancer by Integrating Bone Marrow FDG Uptake and Radiomic Features of Primary Tumor in PET/CT[J]．Cancers，2021，13(14)：3563.
43	Mori M，Passoni P，Incerti E，et al.Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer[J]．Radiother Oncol，2020，153：258-264.
44	Mapelli P，Bezzi C，Palumbo D，et al.68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours[J]．Eur J Nucl Med Mol Imaging，2022，49(7)：2352-2363.
45	Lv L，Xin B，Hao Y，et al.Radiomic analysis for predicting prognosis of colorectal cancer from preoperative ¹⁸F-FDG PET/CT[J]．J Transl Med，2022，20(1)：66.
46	Manfredi S，Lepage C，Hatem C，et al.Epidemiology and management of liver metastases from colorectal cancer[J]．Ann Surg，2006，244(2)：254-259.
47	Rahmim A，Bak-Fredslund KP，Ashrafinia S，et al.Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features[J]．Eur J Radiol，2019，113：101-109.
48	Wilkinson JR，Morris EJA，Downing A，et al.The rising incidence of anal cancer in England 1990-2010：a population-based study[J]．Colorectal Dis，2014，16(7)：O234-239.
49	Brown P J，Zhong J，Frood R，et al.Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT[J]．Eur J Nucl Med Mol Imaging，2019，46(13)：2790-2799.
50	Nakajo M，Jinguji M，Tani A，et al.Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment[18F]-FDG PET/CT to Predict Prognosis of Patients with Endometrial Cancer[J]．Mol Imaging Biol，2021，23(5)：756-765.
51	Nakajo M，Jinguji M，Tani A，et al.Machine learning based evaluation of clinical and pretreatment ¹⁸F-FDG-PET/CT radiomic features to predict prognosis of cervical cancer patients[J]．Abdominal Radiology(New York)，2022，47(2)：838-847.
52	Martone ME.FORCE11：Building the Future for Research Communications and e-Scholarship[J]．BioScience，2015，65(7)：635.
53	Wilkinson MD，Dumontier M，Aalbersberg IJJ，et al.The FAIR Guiding Principles for scientific data management and stewardship[J]．Scientific Data，2016，3：160018.
54	Lambin P，Leijenaar RTH，Deist TM，et al.Radiomics：the bridge between medical imaging and personalized medicine[J]．Nat Rev Clin Oncol，2017，14(12)：749-762.
55	Hosny A，Parmar C，Quackenbush J，et al.Artificial intelligence in radiology[J]．Nat Rev Cancer，2018，18(8)：500-510.
56	Manafi-Farid R，Karamzade-Ziarati N，Vali R，et al.2-[18F]FDG PET/CT radiomics in lung cancer：An overview of the technical aspect and its emerging role in management of the disease[J]．Methods，2021，188：84-97.
57	Zwanenburg A．Radiomics in nuclear medicine：robustness，reproducibility，standardization，and how to avoid data analysis traps and replication crisis[J]．Eur J Nucl Med Mol Imaging，2019，46(13)：2638-2655.
58	Clark K，Vendt B，Smith K，et al.The Cancer Imaging Archive(TCIA)：maintaining and operating a public information repository[J]．Journal of Digital Imaging，2013，26(6)：1045-1057.
59	Buckler A J，Bresolin L，Dunnick NR，et al.A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging[J]．Radiology，2011，258(3)：906-914.
60	Deist TM，Jochems A，van Soest J，et al.Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care：euroCAT[J]．Clin Transl Radiat Oncol，2017，4：24-31.
61	Pesapane F，VolontéC，Codari M，et al.Artificial intelligence as a medical device in radiology：ethical and regulatory issues in Europe and the United States[J]．Insights Imaging，2018，9(5)：745-753.
62	Kaissis GA，Makowski MR，Rückert D，et al.Secure，privacy-preserving and federated machine learning in medical imaging[J]．Nature Machine Intelligence，2020，2(6)：305-311.
63	Rieke N，Hancox J，Li W，et al.The future of digital health with federated learning[J]．NPJ Digit Med，2020，3：119.

[1]	Qian Zhang, Jiahui Chen, Xuemeng Gao, Aoxue Zhao, Ying Huang. Value of radiomics features based on high-frame-rate contrast-enhanced ultrasound in differential diagnosis of benign and malignant thyroid nodules [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 895-903.
[2]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[3]	Jie Shi, Yuntao Li, Haiyan Gao. Prognosis of node-positive luminal A breast cancer patients with neoadjuvant and adjuvant chemotherapy and influencing factors [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 353-361.
[4]	Long Qian, Xiaofeng Lu, Xingzhou Wang, Junfeng Du, Xiaofei Shen, Wenxian Guan. Research progress on nervous system regulation of immune response to gastrointestinal tumors [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 86-89.
[5]	Changqing Cao, Xinyan Guo, Yuan Gao, Cun Zhang, Haili Tang, Dong Fan, Xiaojun Yang, Song Zhang, Huadong Zhao. Research progress on the involvement of tumor microenvironment in mediating trastuzumab resistance in HER2-positive breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 90-95.
[6]	Fengyi Li, Ruofan Li, Xu Gao, Chaofan Zhang. Effect of target-directed liquid intervention on postoperative hemodynamics and gastrointestinal function recovery in elderly patients with gastrointestinal tumors [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 29-32.
[7]	Qian Yang, Cuifang Li, Wanqiu Zhang. Analysis of short-term and long-term prognosis and influencing factors of primary liver cancer with spontaneous ruptured hemorrhage after emergency TACE surgery [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 33-36.
[8]	Yansong Li, Huimin Feng, Mingchao Liu, Zepeng Liu, Qiuxia Jiang. Expression and clinical significance of STIP1 in triple negative breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 52-56.
[9]	Bing Lan, Huaiming Wang, Hui Wang, Bo Ma. Research progress on locally advanced colon cancer with bladder invasion [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 505-511.
[10]	Zhentian Guo, Zongming Zhang, Yue Zhao, Limin Liu, Chong Zhang, Zhuo Liu, Hui Qi, Kun Tian. Machine learning algorithms for predicting postoperative hospital stay in elderly patients with acute cholecystitis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 955-961.
[11]	Yongsheng Li, Jiahe Sun, Shuwei Guo, Yikang Lu, Hongzhou Liu. Short-term postoperative complications and their influencing factors in elderly patients with colorectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 962-967.
[12]	Jun Xu, Yuanyuan Ji, Junping Chen, Jian Wang. Meningioma with rosettes with skull invasion: a case report and literature review [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 916-919.
[13]	Jun Wang, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Libin Suo, Jun Chen, chengli Miao, Chenghua Luo. Retrospective analysis of anesthesia management of massive transfusion patients undergoing retroperitoneal tumor resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 844-849.
[14]	Libin Suo, Kunpeng Liu, Lan Yao, Hua Zhang, Yue Wei, Jun Wang, Jun Chen, Chengli Miao, Chenghua Luo. Key points of anesthesia management and prognostic factors in patients undergoing primary retroperitoneal paraganglioma resection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 771-776.
[15]	Jiayuan Wang, Xiaodong Wang. Progress in research of sarcopenia in digestive system malignant tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 823-827.

Please choose a citation manager

Content to export